Beyond comorbidities: Age as an independent predictor of survival in pulmonary arterial hypertension
- 17 July 2026
- journal article
- Published by Elsevier in European Journal of Internal Medicine
- p. 107083
Abstract
No abstract availableFunding Information
- Sociedad Española de Cardiología
This publication has 9 references indexed in Scilit:
- New phenotype and outcomes in connective tissue disease-associated pulmonary arterial hypertension: relevance of age-related comorbiditiesRheumatology, 2026
- Cellular senescence in adult pulmonary hypertension: current state and future challengesEuropean Respiratory Review, 2025
- Risk assessment in pulmonary arterial hypertension patients with multiple comorbidities and/or advanced age—Where do we stand and what's next?Pulmonary Circulation, 2023
- Pulmonary Arterial Hypertension in the Elderly: Peculiar Features and Challenges for a Proper Phenotyping ApproachJournal of Cardiovascular Development and Disease, 2023
- Hallmarks of aging: An expanding universeCell, 2023
- Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysisThe Journal of Heart and Lung Transplantation, 2022
- Early risk prediction in idiopathicversusconnective tissue disease-associated pulmonary arterial hypertension: call for a refined assessmentERJ Open Research, 2021
- The changing landscape of pulmonary arterial hypertension and implications for patient careEuropean Respiratory Review, 2014
- Survival in pulmonary hypertension in Spain: insights from the Spanish registryEuropean Respiratory Journal, 2012